This resulted in a normalization of BCMA expression on memory B cell subsets in belimumab-treated SLE patients compared to HCs, but BCMA expression remained elevated on naïve and double-negative memory B cells (Figure 3B). Here, TNFRSF17 is linked to systemic lupus erythematosus.